{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:16Z","timestamp":1787003656502,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology","award":["024.004.012"],"award-info":[{"award-number":["024.004.012"]}]},{"name":"NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology","award":["024.004.012"],"award-info":[{"award-number":["024.004.012"]}]},{"name":"NWO Gravitation: BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology","award":["024.004.012"],"award-info":[{"award-number":["024.004.012"]}]},{"name":"Amsterdam Neuroscience Alliance Project"},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Netherlands Organization for Scientific Research","award":["453-14-005"],"award-info":[{"award-number":["453-14-005"]}]},{"name":"European Research Council advanced grant","award":["ERC-2018-AdG GWAS2FUNC 834057"],"award-info":[{"award-number":["ERC-2018-AdG GWAS2FUNC 834057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Proxy phenotypes allow for the utilization of genetic data from large population cohorts to analyze late-onset diseases by using parental diagnoses as a proxy for genetic disease risk. Proxy phenotypes based on parental diagnosis status have been used in previous studies to identify common variants associated with Alzheimer\u2019s disease. As of yet, proxy phenotypes have not been used to identify genes associated with Alzheimer\u2019s disease through rare variants. Here we show that a proxy Alzheimer\u2019s disease\/dementia phenotype can capture known Alzheimer\u2019s disease risk genes through rare variant aggregation. We generated a proxy Alzheimer\u2019s disease\/dementia phenotype for 148,508 unrelated individuals of European ancestry in the UK biobank in order to perform exome-wide rare variant aggregation analyses to identify genes associated with proxy Alzheimer\u2019s disease\/dementia. We identified four genes significantly associated with the proxy phenotype, three of which were significantly associated with proxy Alzheimer\u2019s disease\/dementia in an independent replication cohort consisting of 197,506 unrelated individuals of European ancestry in the UK biobank. All three of the replicated genes have been previously associated with clinically diagnosed Alzheimer\u2019s disease (\n                    <jats:italic>SORL1<\/jats:italic>\n                    ,\n                    <jats:italic>TREM2<\/jats:italic>\n                    , and\n                    <jats:italic>TOMM40\/APOE<\/jats:italic>\n                    ). We show that proxy Alzheimer\u2019s disease\/dementia can be used to identify genes associated with Alzheimer\u2019s disease through rare variant aggregation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-29108-8","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:03:44Z","timestamp":1675753424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rare variant aggregation in 148,508 exomes identifies genes associated with proxy dementia"],"prefix":"10.1038","volume":"13","author":[{"given":"Douglas P.","family":"Wightman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan A.","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Posthuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"29108_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","volume":"7","author":"M Cruts","year":"1998","unstructured":"Cruts, M. et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum. Mol. Genet. 7, 43\u201351 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"29108_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349, 704\u2013706 (1991).","journal-title":"Nature"},{"key":"29108_CR3","first-page":"1034","volume":"48","author":"MA Pericak-Vance","year":"1991","unstructured":"Pericak-Vance, M. A. et al. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48, 1034\u20131050 (1991).","journal-title":"Am. J. Hum. Genet."},{"key":"29108_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41380-018-0112-7","volume":"25","author":"JC Bis","year":"2020","unstructured":"Bis, J. C. et al. Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry 25, 1859\u20131875 (2020).","journal-title":"Mol. Psychiatry"},{"key":"29108_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-200037","volume":"76","author":"K-H Fan","year":"2020","unstructured":"Fan, K.-H. et al. Whole-exome sequencing analysis of Alzheimer\u2019s disease in Non-APOE*4 carriers. J. Alzheimers Dis. 76, 1553\u20131565 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"29108_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ana.24466","volume":"78","author":"BN Vardarajan","year":"2015","unstructured":"Vardarajan, B. N. et al. Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci. Ann. Neurol. 78, 487\u2013498 (2015).","journal-title":"Ann. Neurol."},{"key":"29108_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"29108_CR8","first-page":"12155","volume":"13","author":"J Hoogmartens","year":"2021","unstructured":"Hoogmartens, J., Cacace, R. & Van Broeckhoven, C. Insight into the genetic etiology of Alzheimer\u2019s disease: A comprehensive review of the role of rare variants. Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit. 13, 12155 (2021).","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"29108_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fgene.2014.00369","volume":"5","author":"J Lord","year":"2014","unstructured":"Lord, J., Lu, A. J. & Cruchaga, C. Identification of rare variants in Alzheimer\u2019s disease. Front. Genet. 5, 369 (2014).","journal-title":"Front. Genet."},{"key":"29108_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.22.20159251","author":"H Holstege","year":"2021","unstructured":"Holstege, H. et al. Exome sequencing identifies rare damaging variants in the ATP8B4 and ABCA1 genes as novel risk factors for Alzheimer\u2019s Disease. medRxiv https:\/\/doi.org\/10.1101\/2020.07.22.20159251 (2021).","journal-title":"medRxiv"},{"key":"29108_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ejhg.2017.87","volume":"25","author":"H Holstege","year":"2017","unstructured":"Holstege, H. et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer\u2019s disease: A clinical interpretation strategy. Eur. J. Hum. Genet. 25, 973\u2013981 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"29108_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ng.3766","volume":"49","author":"JZ Liu","year":"2017","unstructured":"Liu, J. Z., Erlich, Y. & Pickrell, J. K. Case-control association mapping by proxy using family history of disease. Nat. Genet. 49, 325\u2013331 (2017).","journal-title":"Nat. Genet."},{"key":"29108_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni, R. E. et al. GWAS on family history of Alzheimer\u2019s disease. Transl. Psychiatry 8, 99 (2018).","journal-title":"Transl. Psychiatry"},{"key":"29108_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"29108_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","volume":"91","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am. J. Hum. Genet. 91, 224\u2013237 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"29108_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"29108_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"29108_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"29108_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song, W. et al. Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 13, 381\u2013387 (2017).","journal-title":"Alzheimers Dement."},{"key":"29108_CR20","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin, S. C. et al. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum. Mol. Genet. 23, 5838\u20135846 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"29108_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich, J. D., Ulland, T. K., Colonna, M. & Holtzman, D. M. Elucidating the role of TREM2 in Alzheimer\u2019s disease. Neuron 94, 237\u2013248 (2017).","journal-title":"Neuron"},{"key":"29108_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2012","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2012).","journal-title":"N. Engl. J. Med."},{"key":"29108_CR23","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","volume":"29","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum. Mol. Genet. 29, 3224\u20133248 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"29108_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acn3.582","volume":"5","author":"NS Raghavan","year":"2018","unstructured":"Raghavan, N. S. et al. Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer\u2019s disease. Ann. Clin. Transl. Neurol. 5, 832\u2013842 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"29108_CR25","doi-asserted-by":"publisher","first-page":"136195","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro, C., Zainab, M. & Tifft, C. J. The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. Neurosci. Lett. 764, 136195 (2021).","journal-title":"Neurosci. Lett."},{"key":"29108_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat. Genet. 53, 1276\u20131282 (2021).","journal-title":"Nat. Genet."},{"key":"29108_CR27","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLOS Med. 12, e1001779 (2015).","journal-title":"PLOS Med."},{"key":"29108_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41588-021-00885-0","volume":"53","author":"JD Szustakowski","year":"2021","unstructured":"Szustakowski, J. D. et al. Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank. Nat. Genet. 53, 942\u2013948 (2021).","journal-title":"Nat. Genet."},{"key":"29108_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","volume":"586","author":"CV Van Hout","year":"2020","unstructured":"Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature 586, 749\u2013756 (2020).","journal-title":"Nature"},{"key":"29108_CR30","unstructured":"GATK TEAM. Evaluating the quality of a germline short variant callset. https:\/\/gatk.broadinstitute.org\/hc\/en-us\/articles\/360035531572."},{"key":"29108_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"29108_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"29108_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"29108_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"29108_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"29108_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"29108_CR37","doi-asserted-by":"publisher","first-page":"s13742","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience 4, s13742 (2015).","journal-title":"Gigascience"},{"key":"29108_CR38","doi-asserted-by":"publisher","first-page":"e8430","DOI":"10.15252\/msb.20188430","volume":"14","author":"O Wagih","year":"2018","unstructured":"Wagih, O. et al. A resource of variant effect predictions of single nucleotide variants in model organisms. Mol. Syst. Biol. 14, e8430 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"29108_CR39","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2018","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2018).","journal-title":"Nucleic Acids Res."},{"key":"29108_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2016)."},{"key":"29108_CR41","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing (2017)."},{"key":"29108_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29108-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:20:31Z","timestamp":1675754431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29108-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29108-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CdL was funded by F. Hoffmann-La Roche AG. No other authors have any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2179"}}